NEW YORK – PathogenDx, which provides DNA-based pathogen testing for the cannabis, hemp, agriculture, and food safety industries, said today that it has raised $7.5 million in a Series B funding round.
The investment round was led by Cresco Capital Partners with participation from Altitude Investment Management, Arcadian Investment Partners, Panther Opportunity Fund, Salveo Capital, Flatiron Venture Partners, and other investors.